RivaXa 10 Tablet

About RivaXa 10 Tablet

RivaXa 10 is a tablet made by Square Pharmaceuticals PLC. It contains rivaroxaban 10 mg and belongs to a group of oral anticoagulant medicines that work on the blood clotting system.

There are 19 brands of Rivaroxaban listed in Bangladesh. The lowest listed price is Rivadel 2.5 Tablet at ৳ 5 per unit.

What is RivaXa 10 Tablet?

RivaXa 10 is an oral anticoagulant tablet from Square Pharmaceuticals PLC. Its active ingredient is rivaroxaban, supplied in a 10 mg strength. Rivaroxaban works by blocking factor Xa, a step in the blood clotting cascade, which reduces the formation of thrombin and clot formation. The 10 mg strength is one of several strengths of this medicine, and different strengths are used for different treatment situations. Anticoagulants are used to lower the risk of harmful blood clots. Because this medicine affects clotting, it should only be taken on a doctor's advice, and the doctor chooses the dose and how long it is used.

Uses of RivaXa 10

RivaXa 10 is used as an anticoagulant. Rivaroxaban is prescribed in different strengths for different situations, including lowering the risk of stroke and systemic embolism in people with nonvalvular atrial fibrillation, treating deep vein thrombosis and pulmonary embolism, and, at a lower strength, preventing atherothrombotic events after an acute coronary syndrome. Which situation applies to you depends on your own condition. Ask your doctor what RivaXa 10 is being prescribed for in your case.

How to use RivaXa 10

RivaXa 10 is a tablet that is swallowed. The doctor decides the dose, how often it is taken, whether it should be taken with food, and how long the course lasts. Do not change the dose or stop the medicine on your own, because stopping an anticoagulant early can raise the risk of clotting unless the doctor has arranged an alternative. If you miss a dose, ask your doctor or pharmacist what to do rather than doubling up. Tell your doctor about all other medicines you take.

Side effects of RivaXa 10

The most common side effect of rivaroxaban is an increased chance of bleeding. Bleeding may appear as bruising, nosebleeds, gum bleeding or blood in the urine or stool, and in some cases it can be serious. Spinal or epidural haematoma has been reported, particularly with neuraxial anaesthesia or spinal puncture. In people with nonvalvular atrial fibrillation, stopping the medicine can increase the risk of stroke. Seek medical help for unusual or persistent bleeding, and ask your doctor about any other effects you notice.

Safety and precautions

RivaXa 10 is not suitable for everyone. It must not be used by anyone with a known allergy to rivaroxaban or the tablet's other ingredients, or with active pathological bleeding. The risk of bleeding is higher in people with bleeding disorders, uncontrolled severe high blood pressure, certain gastrointestinal diseases, vascular retinopathy, bronchiectasis or a history of pulmonary bleeding, so these should be discussed with the doctor first. Rivaroxaban is a pregnancy category C medicine, and dosing in pregnancy has not been established; it is not known whether it passes into breast milk, and safety in breastfeeding has not been established. Pregnant or breastfeeding women, and anyone with kidney or liver problems, should speak to a doctor before use.

Frequently asked questions

What does the generic name rivaroxaban mean?

Rivaroxaban is the generic name of the active ingredient in RivaXa 10. Generic names identify the medicine itself rather than a particular brand, so several manufacturers may make products containing the same ingredient under different brand names.

What is RivaXa 10 used for and what kind of medicine is it?

RivaXa 10 is an oral anticoagulant. Rivaroxaban is used to lower the risk of harmful blood clots in conditions such as nonvalvular atrial fibrillation, deep vein thrombosis and pulmonary embolism, and, at a lower strength, after acute coronary syndrome. Ask your doctor which use applies to you.

How should RivaXa 10 be taken?

It is a tablet that is swallowed. The doctor decides the dose, how often it is taken, whether it is taken with food, and the length of the course. Do not alter or stop it on your own, and ask your doctor or pharmacist if you miss a dose or take other medicines.

Who should check with a doctor before taking RivaXa 10?

People with active bleeding, a known allergy to rivaroxaban, bleeding disorders, uncontrolled severe high blood pressure, certain stomach or bowel diseases, or a history of lung bleeding should speak to a doctor first. Pregnant or breastfeeding women and people with kidney or liver problems should also ask the doctor before use.

Indications

Rivaroxaban 2.5 mg:
  • For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
Rivaroxaban 10-20 mg ... Read moreRivaroxaban 2.5 mg:
  • For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
Rivaroxaban 10-20 mg:
  • To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
  • Deep vein thrombosis (DVT) & pulmonary embolism (PE) and reduction in the risk of recurrence of DVT and of PE
  • For the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery

Pharmacology

Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.

Dosage & Administration

Rivaroxaban 2.5 mg:
  • The recommended dose: 2.5 mg twice daily. Patients should also take a daily dose of 75-100 mg Aspirin or a daily dose of 75-100 mg Aspirin in addition to either a daily dose of 75 mg clopidogrel or a standard daily dose of ticlopidine.
Rivaroxaban 10-20 mg:
  • Nonvalvular Atrial Fibrillation: For patients with Creatinin Clearance >50 mL/min: 20 mg orally, once daily with the evening meal. For patients with Creatinin Clearance 15-50 ml/min: 15 mg orally, once daily with the evening meal.
  • Treatment of DVT & PE: 15 mg orally twice daily with food for the first 21 days for the initial treatment of acute DVT or PE. After the initial treatment period, 20 mg orally once daily with food for the remaining treatment.
  • Prevention in the risk of recurrence of DVT and of PE: 20 mg once daily with food.
  • Prophylaxis of DVT following Hip replacement surgery: 10 mg once daily for 35 days.
  • Prophylaxis of DVT following knee replacement surgery: 10 mg once daily for 12 days.
May be taken with or without food.

Interaction

Concomitant use with drugs that are combined P-gp and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil, dronedarone) increases in Rivaroxaban exposure and pharmacodynamic effects (i.e., factor Xa inhibition and PT prolongation), that’s why should be avoided. Co-administration of Rivaroxaban with a combined P-gp and strong CYP3A4 inducer (e.g., rifampicin, phenytoin, carbamazepine) decreases the efficacy of Rivaroxaban and also should be avoided. The concomitant use of other drugs like anti-platelet agents, heparin, fibrinolytic therapy, NSAIDs may cause an increased risk of bleeding.

Contraindications

It is contraindicated in patients with known hypersensitivity of Rivaroxaban or any of the excipients of the product. It is also contraindicated in patients with active pathological bleeding.

Side Effects

The most common side effects of Rivaroxaban have increased chance of bleeding, spinal or epidural hematoma and increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.

Pregnancy & Lactation

Rivaroxaban is a pregnancy category C drug. There are no adequate or well-controlled studies of Rivaroxaban in pregnant women, and dosing for pregnant women has not been established. It is not known if Rivaroxaban is excreted in human milk. The safety and efficacy of Rivaroxaban has not been established in breastfeeding women.

Precautions & Warnings

Early discontinuation of Rivaroxaban, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. Rivaroxaban increases the risk of bleeding that can be fatal in presence of following risk factors- bleeding disorders, uncontrolled severe arterial hypertension, gastrointestinal disease (e.g., inflammatory bowel disease, oesophagitis, gastritis and gastroesophageal reflux disease), vascular retinopathy, bronchiectasis, history of pulmonary bleeding. Signs or symptoms of neurological impairment should be monitored in case of neuraxial anesthesia (spinal/epidural anesthesia) or spinal puncture as epidural or spinal hematoma can occur. Rivaroxaban is not recommended in patients with pulmonary embolism who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy.

Overdose Effects

Overdose of Rivaroxaban may lead to hemorrhage. Rivaroxaban systemic exposure is not further increased at single doses >50 mg due to limited absorption. A specific antidote for Rivaroxaban is not available. The use of activated charcoal to reduce absorption in case of Rivaroxaban overdose may be considered. Partial reversal of laboratory anticoagulation parameters may be achieved with use of plasma products.

Storage Conditions

Store in a cool (below 30°C) & dry place protected from light. Keep away from the reach of children.

Alternative brands of Rivaroxaban

Other brands with the same generic name, cheapest first.

See all 19 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.